Literature DB >> 24515458

Immunization, hybridoma generation, and selection for monoclonal antibody production.

Hyung-Yong Kim1, Alexander Stojadinovic, Mina J Izadjoo.   

Abstract

Monoclonal antibodies (MAbs) produced by a single clone of cells with homogeneous binding specificity for an antigenic determinant have been used in diagnostics and therapeutics. Many new methods have been devised by scientists for making hybridomas and MAbs. The three major steps for producing MAbs are immunization, immortalization, and isolation. Here, we describe technical details of the three important steps for generating mouse hybridomas and MAbs.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24515458     DOI: 10.1007/978-1-62703-992-5_3

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  4 in total

Review 1.  Challenges in Antibody Development against Tn and Sialyl-Tn Antigens.

Authors:  Liliana R Loureiro; Mylène A Carrascal; Ana Barbas; José S Ramalho; Carlos Novo; Philippe Delannoy; Paula A Videira
Journal:  Biomolecules       Date:  2015-08-11

2.  A promising detection candidate for flagellated Salmonella spp.

Authors:  Yi Yang; Jiangying Zhang; Chunhong Zhu; Xia Meng; Shuhong Sun; Guoqiang Zhu
Journal:  AMB Express       Date:  2019-08-14       Impact factor: 3.298

3.  Establishment of Murine Hybridoma Cells Producing Antibodies against Spike Protein of SARS-CoV-2.

Authors:  Nadezhda V Antipova; Tatyana D Larionova; Andrei E Siniavin; Maria A Nikiforova; Vladimir A Gushchin; Igor I Babichenko; Alexey V Volkov; Michail I Shakhparonov; Marat S Pavlyukov
Journal:  Int J Mol Sci       Date:  2020-12-01       Impact factor: 5.923

4.  Generation of a Novel High-Affinity Antibody Binding to PCSK9 Catalytic Domain with Slow Dissociation Rate by CDR-Grafting, Alanine Scanning and Saturated Site-Directed Mutagenesis for Favorably Treating Hypercholesterolemia.

Authors:  Zhengli Bai; Menglong Xu; Ying Mei; Tuo Hu; Panpan Zhang; Manman Chen; Wenxiu Lv; Chenchen Lu; Shuhua Tan
Journal:  Biomedicines       Date:  2021-11-27
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.